Book Navigation
 

International Guideline Library update

New Publications published in the International Guideline Library – 04th March to 13th May 2013. Editor’s pick from the guidelines library update. Standards for Clinical Practice Guidelines

Organisation

ACP (US)

Screening for Prostate Cancer: A Guidance Statement from the Clinical Guidelines Committee of the American College of Physicians

AHRQ (US)

Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years — United States, 2013. Centers for Disease Control and Prevention. NGC:009590

AHRQ (US)

Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older — United States, 2013. Centers for Disease Control and Prevention. NGC:009579

AHRQ (US)

Benefits and risks of sterilization. American College of Obstetricians and Gynecologists. NGC:009574

AHRQ (US)

Guideline on the management of bleeding in patients on antithrombotic agents. British Committee for Standards in Haematology. NGC:009478

AHS (CA)

Adjuvant Radiotherapy for Invasive Breast Cancer

ASCO (US)

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

AWMF (DE)

Fluoridierungsmaßnahmen zur Kariesprophylaxe. S2k-LL (DGZMK, DGKFO, DGKJ)

[Dental caries prophylaxis]

AWMF (DE)

Hypersalivation. S2k-LL (DGHNO, DGPP, DGPPN)

[Hypersalivation]

CAP (US)

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

HAS (FR)

Thrombasthénie de Glanzmann. Guide ALD

ICEBM (IR)

درمان اكسپوژر پوسيدگي با يا بدون علائم پالپيت برگشت ناپذير در دندانهاي دائمي زنده

[Management of Carious Pulp Exposure in Vital Permanent Teeth]

IDSA (US)

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

IQWiG (DE)

Addendum zum Auftrag A12-15 Crizotinib

[Addendum to Commission A12-15 Crizotinib]

IQWiG (DE)

Addendum zum Auftrag A12-16 Saxagliptin-Metformin

[Addendum to Commission A12-16 Saxagliptin/metformin]

IQWiG (DE)

Aflibercept - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

[Aflibercept - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]

IQWiG (DE)

Apixaban - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

[Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]

IQWiG (DE)

Brentuximab Vedotin - Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V (Dossierbewertung)

[Brentuximab Vedotin - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment)]

IQWiG (DE)

Dapagliflozin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

[Dapagliflozin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]

IQWiG (DE)

Pixantron - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)

[Pixantrone - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]

KCE (BE)

Ankle sprains: diagnosis and therapy

MoH (UA)

Dementia

KCE (BE)

Supportive treatment for cancer - Part 2: Prevention and treatment of adverse events related to chemotherapy and radiotherapy

NICE (UK)

Conduct disorders in children and young people (CG158)

NICE (UK)

Fertility (CG156)

NICE (UK)

Hyperphosphataemia in chronic kidney disease (CG157)

SIGN (GB)

Brain injury rehabilitation in adults (SIGN CPG 130)

Editor’s pick from the guidelines library update

As always we offer you many good, useful and interesting documents in the G-I-N Guidelines library update. I encourage all to browse through to find the documents of most relevance to you. I will draw your attention to three entries this time.

There is and has been a lot of controversy in many countries about PSA testing/screening for early detection of prostate cancer. American College of Physicians has published a review of guidelines about this topic: ‘ Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians.’ The conclusion is clear: ‘ACP recommends that clinicians should not screen for prostate cancer using the prostate-specific antigen test in average-risk men under the age of 50 years, men over the age of 69 years, or men with a life expectancy of less than 10 to 15 years. Read more: http://annals.org/article.aspx?articleid=1676183

The Centers for Disease Control and Prevention in the US (CDC) and its Advisory Committee on Immunization Practices every year reviews the evidence and publish updates of the child immunization program in the US. International collaboration between CDC, the GRADE working group, the European Centre for Disease prevention and Control, the Robert Koch Institute in Germany and National Immunization Advisory Committees has also taken part to further develop the evidence based methodology for immunization guidance. These guidelines are treasures for all who need to update national immunization programs: Read more: www.guideline.gov/content.aspx?id=39538

The Belgian Healthcare Knowledge Center has published new guidelines for Ankle Sprains, https://kce.fgov.be/publication/report/ankle-sprains-diagnosis-and-therapy. This is a very interesting document, both regarding its practical content for a common painful health condition, but also for the methodological discussions regarding developing guidelines when there is lack of sound evidence, like this quote from the introduction indicates: ‘That same tension between scientific proof (or the lack of it) and clinical expertise and experience of course came to the fore in the discussions with clinicians and experts during the course of the study. It brought us to formulate a number of additional recommendations, based on expert consensus.’

Frode Forland
F.Forland@kit.nl

Standards for Clinical Practice Guidelines

Dear Friends:

I was recently invited to write an expert commentary for the National Guideline Clearinghouse (NGC) and National Quality Measures Clearinghouse (NQMC) Web sites regarding recent guideline standards developed by the Guidelines International Network and the Institute of Medicine. I tried to highlight the similarities between the standards, issues related to their implementation, and addressed some of the criticism. This paper was published in April 2013 (1) and would be happy to hear your thoughts, that can be shared on the NGC’s website, or you can email them to me.

With warm regards,

Amir Qaseem, MD, PhD, Chair of the Guidelines International Network (G-I-N)
Director, Clinical Policy, American College of Physicians
aqaseem@acponline.org
+1 215 3512570

www.guidelines.gov/expert/expert-commentary.aspx?id=43913

 
enGINe Newsletter

Subscribe here to the enGINe Newsletter.


Page last updated: Jun 07, 2013
Copyright © 2002-2016 Guidelines International Network.
All rights reserved

The Guidelines International Network is formally constituted as a Scottish Guarantee Company under Company Number SC243691 and recognised as a Scottish Charity under Scottish Charity Number SC034047 with its Registered Office at J. & H. Mitchell W.S., 51 Atholl Road, Pitlochry, Perthshire PH16 5BU, Scotland.

Back to top